Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial

Oncotarget. 2019 Apr 19;10(29):2791-2792. doi: 10.18632/oncotarget.26870.

Authors

Federica Marmorino¹, Alfredo Falcone¹, Chiara Cremolini¹

Affiliation

¹ Chiara Cremolini: Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.

No abstract available

Keywords: bevacizumab; maintenance; metastatic colorectal cancer.

Publication types

Editorial